A carregar...

THERAPEUTIC WHITE BLOOD CELL AND PLATELET DEPLETIONS USING THE SPECTRA OPTIA SYSTEM CONTINUOUS MONONUCLEAR CELL PROTOCOL

The Spectra Optia apheresis system® has only recently been approved by the Food and Drug Administration (FDA) for therapeutic white blood cell (WBC) and is not yet approved for platelet depletions. Prior to FDA-approval of the WBC depletion protocol, when our available COBE Spectra apheresis systems...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Apher
Main Authors: Cates, Nancy C., Oakley, Darlene J., Onwuemene, Oluwatoyosi A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6852644/
https://ncbi.nlm.nih.gov/pubmed/30325054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jca.21644
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!